Molecular epidemiology of yadA-positive Yersinia enterocolitica

M. Fredriksson-Ahomaa

2001-06-01

Abstract:

What problem does this paper attempt to address?

Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.

M. Rousseau,H. Pouleur,J. Debaisieux,C. van Eyll,A. Charlier

DOI: https://doi.org/10.1111/J.1365-2125.1989.TB03582.X

1989-02-01

British Journal of Clinical Pharmacology

Abstract:Impaired left ventricular diastolic dysfunction is common in patients with ischaemic heart failure. The beta 1-adrenoceptor partial agonist xamoterol was compared with pindolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity, in a haemodynamic study in 17 patients with ischaemic heart disease. Pindolol caused left ventricular end-diastolic pressure, wall stress and T1 to rise, whereas xamoterol produced improvements in all three parameters. These results suggest that xamoterol may be of greater benefit to patients in heart failure.
On the diameter of the generalized undirected de Bruijn graphs UGB(n,m), n2 < m ≤ n3

Jyhmin Kuo,H. Fu

DOI: https://doi.org/10.1002/net.20228

2008-12-01

Networks

Abstract:The generalized de Bruijn digraph GB(n,m) is the digraph (V,A) where V = {0, 1,…,m − 1} and (i,j) ∈ A if and only if j ≡ in+α (mod m) for some α ∈ {0, 1, 2,…,n− 1}. By replacing each arc of GB(n,m) with an undirected edge and eliminating loops and multi‐edges, we obtain the generalized undirected de Bruijn graph UGB(n,m). In this article, we prove that when 2n2 ≤ m ≤ n3 the diameter of UGB(n,m) is equal to 3. We also show that for pairs (n,m) where n2
Adrenergic mechanisms in canine mesenteric circulation.

K. Swan,D. Reynolds

Abstract:
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)

Doris Helbig,Mirjana Ziemer,Edgar Dippel,Michael Erdmann,Uwe Hillen,Ulrike Leiter,Thomas Mentzel,Georg Osterhoff,Selma Ugurel,Jochen Utikal,Dagmar von Bubnoff,Carsten Weishaupt,Stephan Grabbe

DOI: https://doi.org/10.1111/ddg.14700

Abstract:Atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) are rare cutaneous neoplasms representing histomorphological, genetic as well as epigenetic variants of a disease spectrum. Both tumors typically manifest as nonspecific, often ulcerated, skin- to flesh-colored nodules in chronically sun-damaged skin of elderly male patients. AFX is a rather well demarcated, often rapidly growing tumor. PDS tumors are poorly circumscribed and are characterized by aggressive infiltrative growth. Fast as well as slow growth behavior has been reported for both tumors. Histologically, both are composed of spindle-shaped and epithelioid tumor cells with pleomorphic nuclei as well as atypical multinucleated giant cells. Atypical mitoses are common. In contrast to AFX, PDS involves relevant parts of the subcutis and shows areas of tumor necrosis and/or perineural infiltration. Due to the poorly differentiated nature of AFX/PDS (Grade 3), histopathologically similar cutaneous sarcomas, undifferentiated carcinomas, melanomas and other diseases have to be excluded by immunohistochemical analysis. The treatment of choice is micrographically controlled surgery. In cases of AFX, a cure can be assumed after complete excision. Local recurrence rates are low as long as PDS tumors are surgically removed with a safety margin of 2 cm. Metastasis is rare and mostly associated with very thick or incompletely excised tumors; it mainly affects the skin and lymph nodes. Distant metastasis is even more rare. No approved and effective systemic therapy has been established.
An Evaluation of Information Transfer Through the Continuum of Surgical Care: A Feasibility Study

K. Nagpal,A. Vats,K. Ahmed,C. Vincent,K. Moorthy

DOI: https://doi.org/10.1097/SLA.0b013e3181e986df

IF: 13.787

2010-08-01

Annals of Surgery

Abstract:Objective:To evaluate information transfer and communication (ITC) across the surgical care pathway with the use of Information Transfer and Communication Assessment Tool for Surgery (ITCAS). Background:Communication failures are the leading cause of surgical errors and adverse events. It is vital to assess the ITC across the entire surgical continuum of care to understand the process, to study teams, and to prioritize the phases for intervention. Methods:Twenty patients undergoing major gastrointestinal procedures were followed through their entire surgical care, and ITC process was assessed using ITCAS. ITCAS consisted of 4 checklists for 4 phases of the surgical care. Results:ITC failures are distributed across the entire surgical continuum of care. Preprocedural teamwork and postoperative handover phases have the maximum number of ITC failures (61.7% and 52.4%, respectively). Moreover, it was found that information degrades as it crosses from one phase to another. Of patients, 75% had clinical incidents or adverse events because of ITC failures. Conclusions:The study demonstrated that ITC failures are ubiquitous across surgical care pathway and there is an imminent need to modify current ITC practices. Standardization of ITC through use of checklists, protocols, or information technology is essential to reduce these communication failures.
Two Ca2(+)-binding proteins in the mitotic apparatus of sea urchin eggs.

S. Maekawa,M. Toriyama,H. Sakai

DOI: https://doi.org/10.1016/0014-4827(91)90137-J

IF: 4.145

1991-05-01

Experimental Cell Research

Abstract:
Interpretation bias 1 Title : Interpretation of ambiguous situations : evidence for a dissociation between social and physical threat in Williams syndrome Running Head : Interpretation bias in WS

H. Dodd,M. Porter

Abstract:
Interferon regulatory factor-2 is protective against hepatic ischemia-reperfusion injury.

J. Klune,R. Dhupar,Shoko Kimura,S. Ueki,Jon S. Cardinal,A. Nakao,G. Nace,J. Evankovich,N. Murase,A. Tsung,D. Geller

DOI: https://doi.org/10.1152/ajpgi.00050.2012

2012-09-01

Abstract:Interferon regulatory factor (IRF)-1 is a nuclear transcription factor that induces inflammatory cytokine mediators and contributes to hepatic ischemia-reperfusion (I/R) injury. No strategies to mitigate IRF1-mediated liver damage exist. IRF2 is a structurally similar endogenous protein that competes with IRF1 for DNA binding sites in IRF-responsive target genes and acts as a competitive inhibitor. However, the role of IRF2 in hepatic injury during hypoxic or inflammatory conditions is unknown. We hypothesize that IRF2 overexpression may mitigate IRF1-mediated I/R damage. Endogenous IRF2 is basally expressed in normal livers and is mildly increased by ischemia alone. Overexpression of IRF2 protects against hepatic warm I/R injury. Furthermore, we demonstrate that IRF2 overexpression limits production of IRF1-dependent proinflammatory genes, such as IL-12, IFNβ, and inducible nitric oxide synthase, even in the presence of IRF1 induction. Additionally, isograft liver transplantation with IRF2 heterozygote knockout (IRF2(+/-)) donor grafts that have reduced endogenous IRF2 levels results in worse injury following cold I/R during murine orthotopic liver transplantation. These findings indicate that endogenous intrahepatic IRF2 protein is protective, because the IRF2-deficient liver donor grafts exhibited increased liver damage compared with the wild-type donor grafts. In summary, IRF2 overexpression protects against I/R injury by decreasing IRF1-dependent injury and may represent a novel therapeutic strategy.
Variability of the composition of fish oils: significance for the diet

C. Moffat,A. Mcgill

DOI: https://doi.org/10.1079/PNS19930085

1993-10-01

Proceedings of The Nutrition Society

Abstract:Photosynthesis by most algae and phytoplankton is associated with the production of n-3 polyunsaturated fatty acids (PUFA) . These acids, members of the a-linolenic family, eventually pass through the food web and are incorporated into fish lipids and, thus, form an integral part of our diet either through consumption of fish, fish oils or the flesh of terrestrial animals subjected to a diet containing fish or fish products. Our consumption of fish has a long history. In palaeolithic times, man was already enjoying crustaceans and molluscs while fossilized remains of hand-caught fish date back 380 000 years. Methods of preservation, including smoking and drying, were developed thus allowing increased utilization of this food. Since the forging of a link between the consumption of n-3 fatty acids and benefits to health, many detailed studies have been carried out to investigate the influence of fish oils on various physiological processes. The term fish oil, used generically, embraces a complex matrix of components in which there are differences in composition depending on the species of fish from which the oil is obtained. This overview attempts to provide an insight into the range of molecular species present in fish oils and to emphasize the importance of characterizing the composition of products used in feeding trials and physiological studies.
Copy number variations in atypical fibroxanthomas and pleomorphic dermal sarcomas

Doris Helbig,Alexander Quaas,Cornelia Mauch,Sabine Merkelbach-Bruse,Reinhard Büttner,Michael Emberger,Marion Wobser,Vanessa Rüsseler,Katharina Pütz,Elke Binot,Jan Rehker,Jan Budczies,Michaela Angelika Ihle

DOI: https://doi.org/10.18632/oncotarget.22691

2017-11-25

Oncotarget

Abstract:Atypical fibroxanthomas (AFX) and pleomorphic dermal sarcomas (PDS) are frequent cutaneous sarcomas typically arising on sun-exposed skin in elderly patients. In contrast to AFX, which generally do not recur after complete excision, PDS locally recur in up to 50% and metastasize in up to 20%. We recently detected characteristic UV-induced TP53 mutations as potential driver mutation in almost all PDS investigated as well as activating PIK3CA and RAS gene mutations in around one third of our tumors representing targets for personalized treatments in patients with unresectable or metastasized PDS. In the present study, we identified amplifications and deletions in a small part of the PDS (6 of 27 cases) but not in AFX suggesting that copy number variations (CNV) might not be an initial event in tumor development but rather important during tumor progression. In addition to BRAF, KNSTRN, IDH1 and PDGFRA amplification, CNV analyses revealed deletions in the CDKN2A, KIT and PDGFRA genes. In cases where an appropriate FISH assay was established, the CNV results could be verified by FISH analysis. Amplification of BRAF, KIT or PDGFRA and/or losses of CDKN2A might represent bad prognostic markers, although larger studies are needed to clarify their association with prognosis or progression in PDS.
Study on possibilities of reconstructive--plastic surgery in patients with stage III breast cancer.

Ismagilov Ak,R. Khasanov,Navrusov Sn,Beknazarov Zp

Bratislava Medical Journal

Abstract:BACKGROUND This population based study aimed to use reconstructive-plastic surgery with autologous tissue as a treatment of patients with stage III breast cancer. PATIENTS AND METHODS We identified women (374) diagnosed with stage III breast cancer between 2000 and 2009 years. We compared radical operations with and without a plastic step, where 29 patients underwent the surgery in combination with an immediate radical resection with LD-flap replacement, mastectomy concurrently to TRAM-flap reconstruction in 103 patients. RESULTS We examined the immediate and remote results of therapy. In data analysis, there were higher summarized indices of physical and mental health rates in patients who underwent the reconstruction plastic surgery compared to patients with mastectomy. All treated women 5 -year survival rate was 77.4+3.6 %, 63.5+3.2% and 40.1+3.1 % in stages IIIa, IIIb, IIIc respectively. In the control group, the rates were 78.6+3.4 %, 64.0+3.3 %, and 39.3+3.1 % (p<0.05) respectively. CONCLUSION Our results showed that women with stage III breast cancer who underwent reconstructive-plastic surgeries had a chance to improve their quality of life, and did not increase the frequency, neither did reduce 5 year survival (Tab. 2, Fig. 4, Ref. 19). Full Text in free PDF www.bmj.sk.
Proteomic analysis of pleomorphic dermal sarcoma reveals a fibroblastic cell of origin and distinct immune evasion mechanisms

Sebastian Klein,Yuri Tolkach,Hans Christian Reinhardt,Reinhard Buettner,Alexander Quaas,Doris Helbig

DOI: https://doi.org/10.1038/s41598-024-62927-x

IF: 4.6

2024-06-01

Scientific Reports

Abstract:Pleomorphic dermal sarcomas are infrequent neoplastic skin tumors, manifesting in regions of the skin exposed to ultraviolet radiation. Diagnosing the entity can be challenging and therapeutic options are limited. We analyzed 20 samples of normal healthy skin tissue (SNT), 27 malignant melanomas (MM), 20 cutaneous squamous cell carcinomas (cSCC), and 24 pleomorphic dermal sarcomas (PDS) using mass spectrometry. We explored a potential cell of origin in PDS and validated our findings using publicly available single-cell sequencing data. By correlating tumor purity (TP), inferred by both RNA- and DNA-sequencing, to protein abundance, we found that fibroblasts shared most of the proteins correlating to TP. This observation could also be made using publicly available SNT single cell sequencing data. Moreover, we studied relevant pathways of receptor/ligand (R/L) interactions. Analysis of R/L interactions revealed distinct pathways in cSCC, MM and PDS, with a prominent role of PDGFRB-PDGFD R/L interactions and upregulation of PI3K/AKT signaling pathway. By studying differentially expressed proteins between cSCC and PDS, markers such as MAP1B could differentiate between these two entities. To this end, we studied proteins associated with immunosuppression in PDS, uncovering that immunologically cold PDS cases shared a "negative regulation of interferon-gamma signaling" according to overrepresentation analysis.

multidisciplinary sciences
Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers

Thomas Kuntz,Julian Siebdrath,Silke C Hofmann,Mehmet Baltaci,Jörg Schaller,Martin Hellmich,Luise Stach von Goltzheim,Chalid Assaf,Frank Oellig,Alena-Lioba Michalowitz,Doris Helbig,Alexander Kreuter

DOI: https://doi.org/10.1111/ddg.14911

Abstract:Background and objectives: In recent years, considerable insight has been gained into the pathogenesis, diagnosis and treatment of cutaneous sarcomas, including atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS). Both entities have shown increasing incidence rates in the last decade. This study was initiated to evaluate how these new insights impact the number of diagnoses of AFX/PDS compared to other cutaneous sarcoma entities. Patients and methods: In a retrospective study of four German skin cancer centers, all histopathological reports of cutaneous sarcomas (AFX, PDS, dermatofibrosarcoma protuberans, cutaneous leiomyosarcoma, angiosarcoma, and Kaposi sarcoma) confirmed by board-certified dermatopathologists were analyzed during a time-period of seven years (2013-2019). Additionally, utilization of immunohistochemical markers (including pan-cytokeratin, S100, desmin, CD34, CD10, procollagen-1, CD99, CD14, and CD68) as an adjunct to diagnose AFX/PDS was recorded. Results: Overall, 255 cutaneous sarcomas were included in the present study. The diagnosis of a cutaneous sarcoma has consequently risen from 2013 to 2019 (from 16 to 52 annual cases). The results of AFX/PDS revealed 4.6 times more diagnoses in 2019 than in 2013. Atypical fibroxanthoma represented the most common subtype, displaying 49.3 % of all diagnosed cutaneous sarcomas. Additionally, the increase of AFX/PDS was linked to the use of immunohistochemistry, with specific immunohistochemical markers used in 57.1 % of cases in 2013 compared to 100 % in 2019. Conclusions: This retrospective study of four German skin cancer centers demonstrates a substantial rise of AFX/PDS, possibly due to recently established diagnostic and terminology standards. This rise is probably linked to increased utilization of specific immunohistochemical markers. Atypical fibroxanthoma/PDS may be more common than previously thought and seems to represent the most frequent cutaneous sarcoma subtype.
Atypical fibroxanthoma and pleomorphic dermal sarcoma: Is superficial infiltration in subcutaneous tissue acceptable in AFX?

Dominique van Midden,Uta E. Flucke,Avital L. Amir,Johannes J. Bonenkamp,Satish F.K. Lubeek,Willeke A.M. Blokx

DOI: https://doi.org/10.1016/j.anndiagpath.2022.151915

IF: 2.134

2022-06-01

Annals of Diagnostic Pathology

Abstract:BACKGROUND: Atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) are rare cutaneous neoplasms forming a spectrum. Case reports with recurrences and metastasis have been published despite the current view that AFX is benign. The aim of this study was to identify clinical and histopathological features that predict tumor recurrence.METHODS: A retrospective review of AFX and PDS cases was performed. Clinical characteristics were obtained from patient records.RESULTS: A total of 29 AFX and 23 PDS cases were identified. Review led to re-classification of 12 cases (18%). In 14/50 (26.9%) cases a recurrence occurred. Recurrences were significantly more likely to occur when the tumor showed any infiltration in the subcutaneous fat (100% vs 43.2%, p = 0.000) or when the tumor diameter exceeded 2 cm (46.2% vs 16.2%, p = 0.030).CONCLUSIONS: This study shows that histopathological distinction between AFX and PDS remains difficult with reclassification in 12 out of 52 (18%) cases upon review. All AFX cases solely confined to the dermis behaved benign. We therefore advocate to classify all cases with any form of subcutaneous extension as PDS, and only lesions without as AFX. This contrasts with the current general opinion in which superficial subcutaneous invasion is still accepted in AFX.

pathology
The large extracellular space of scalp: its relationship to brain scanning and cranial impedance plethysmography.

W. Oldendorf

Abstract:
The Usefulness of Ultrasonography for Supporting the Differentiation, Diagnosis, and Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma

Diana Crisan,Lars Alexander Schneider,Karin Scharffetter‐Kochanek,Lukas Bernhard,Maria Crisan,Ximena Wortsman

DOI: https://doi.org/10.1002/jum.16478

2024-05-05

Journal of Ultrasound in Medicine

Abstract:Atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) are rare histomorphological variants of a disease spectrum. After ruling out other tumor entities by immunohistochemistry, PDS can be differentiated from AFX by infiltration into the subcutis, while AFX remains confined to the dermis. The therapeutic approach is more aggressive in PDS as it can potentially metastasize. We assessed the usefulness of preoperative sonography in differentiating between the two tumor entities by identifying a potential subcutaneous infiltration. In our patients (n = 13), preoperative sonography identified and differentiated AFX and PDS with 100% accuracy and even changed the initial histological suspicion of AFX to PDS in 3 cases (23%), which was confirmed after tumor resection. Preoperative sonography of these tumors could strengthen the clinical diagnosis, avoid a delay in therapy initiation and improve patient counseling. While for AFX, micrographic‐controlled surgery suffices, for PDS, resection with 2 cm safety margins and lymph node sonography to rule out lymphonodal involvement is necessary. Hence, ultrasonography can improve clinical practice by providing helpful information for dermatosurgeons, which cannot be obtained during clinical examination.

radiology, nuclear medicine & medical imaging,acoustics
Treatment integrity in a home-based pre-reading intervention programme.

Sandra G van Otterloo,A. van der Leij,Esther Veldkamp

DOI: https://doi.org/10.1002/DYS.311

2006-08-01

Dyslexia

Abstract:Treatment integrity is an underexposed issue in the phonological awareness intervention research. The current study assessed the integrity of treatment of the families (N = 32) participating in the experimental condition of a home-based pre-reading intervention study. The participating kindergartners were all genetically at risk for developing dyslexia. Two aspects of treatment integrity, the number of lessons completed (quantity) and the quality of the administration of the programme (observed in a videotaped session), were investigated. The level of treatment integrity turned out to be 66% when completion of all lessons was taken as quantitative criterion, and about 74% when quality of the parent-child interaction was assessed. The two measures could predict the pre-reading skills at the end of kindergarten. Together they accounted for 43% of the variance in this dependent variable. Together with pre-reading scores at the pre-test the total predicted variance was 87%. The number of lessons completed still contributed 12% to the prediction after controlling for pre-test scores. The results indicated that treatment integrity indeed appears to be an important aspect of treatment outcome and should therefore be included in intervention studies.
High intratumoural 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma

Thilo Gambichler,Fahimeh Razeghpour,Emilia Sorescu,Markus Stücker,Nessr Abu Rached,Jürgen C Becker,Laura Susok

DOI: https://doi.org/10.1093/bjd/ljae171

IF: 11.113

2024-04-26

British Journal of Dermatology

Abstract:Hydroxymethylation plays a significant role in cancer development and progression.1-6 We hypothesized that hydroxymethylation markers may have prognostic potential in AFX/PDS (atypical fibroxanthoma/pleomorphic dermal sarcoma) as also observed in other tumours. Moreover, we wanted to find out whether hydroxymethylation markers may aid the differentiation between AFX and PDS.

dermatology
Genomic analysis of atypical fibroxanthoma

Kevin Lai,Catherine A Harwood,Karin J Purdie,Charlotte M Proby,Irene M Leigh,Namita Ravi,Thaddeus W Mully,Lionel Brooks,Priscilla M Sandoval,Michael D Rosenblum,Sarah T Arron

DOI: https://doi.org/10.1371/journal.pone.0188272

IF: 3.7

2017-11-15

PLoS ONE

Abstract:Atypical fibroxanthoma (AFX), is a rare type of skin cancer affecting older individuals with sun damaged skin. Since there is limited genomic information about AFX, our study seeks to improve the understanding of AFX through whole-exome and RNA sequencing of 8 matched tumor-normal samples. AFX is a highly mutated malignancy with recurrent mutations in a number of genes, including COL11A1, ERBB4, CSMD3, and FAT1. The majority of mutations identified were UV signature (C>T in dipyrimidines). We observed deletion of chromosomal segments on chr9p and chr13q, including tumor suppressor genes such as KANK1 and CDKN2A, but no gene fusions were found. Gene expression profiling revealed several biological pathways that are upregulated in AFX, including tumor associated macrophage response, GPCR signaling, and epithelial to mesenchymal transition (EMT). To further investigate the presence of EMT in AFX, we conducted a gene expression meta-analysis that incorporated RNA-seq data from dermal fibroblasts and keratinocytes. Ours is the first study to employ high throughput sequencing for molecular profiling of AFX. These data provide valuable insights to inform models of carcinogenesis and additional research towards tumor-directed therapy.
Pleomorphic Dermal Sarcoma: A Clinical and Histopathologic Emulator of Atypical Fibroxanthoma, but Different Biologic Behavior

Michael Carletti,Daniel A Nguyen,Peter Malouf,Zachary Ingersoll,Gregory A Hosler,Stephen E Weis

DOI: https://doi.org/10.36518/2689-0216.1334

2022-10-31

Abstract:Description Pleomorphic dermal sarcoma (PDS) can clinically and histopathologically mimic atypical fibroxanthoma (AFX). However, it has a more aggressive clinical course with a higher recurrence rate and metastatic potential. This case presentation aims to report a rapidly-growing, exophytic, 4 cm tumor following a non-diagnostic shave biopsy 2 months prior and to highlight distinctive features between PDS and AFX needed to make the correct diagnosis. Like AFX, PDS occurs on the sun-damaged skin of the elderly, usually on the head and neck. Also, like AFX, PDS histopathologically consists of sheets or fascicles of epithelioid and/or spindle-shaped cells, often with multinucleation, pleomorphism, and numerous mitotic figures. Immunohistochemistry cannot distinguish PDS from AFX but is used to exclude other malignancies. PDS can be distinguished from AFX by size (PDS is usually >2.0 cm) and by the presence of more aggressive histopathologic features, such as subcutaneous involvement, perineural and/or lymphovascular invasion, and necrosis. PDS is a rare entity not well documented in the literature with confusing, misleading, and changing nomenclature. PDS is a diagnosis of exclusion made after complete excision of the tumor with the aid of histopathology and immunohistochemistry.

Molecular epidemiology of yadA-positive Yersinia enterocolitica

Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.

On the diameter of the generalized undirected de Bruijn graphs UGB(n,m), n2 < m ≤ n3

Adrenergic mechanisms in canine mesenteric circulation.

S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)

An Evaluation of Information Transfer Through the Continuum of Surgical Care: A Feasibility Study

Two Ca2(+)-binding proteins in the mitotic apparatus of sea urchin eggs.

Interpretation bias 1 Title : Interpretation of ambiguous situations : evidence for a dissociation between social and physical threat in Williams syndrome Running Head : Interpretation bias in WS

Interferon regulatory factor-2 is protective against hepatic ischemia-reperfusion injury.

Variability of the composition of fish oils: significance for the diet

Copy number variations in atypical fibroxanthomas and pleomorphic dermal sarcomas

Study on possibilities of reconstructive--plastic surgery in patients with stage III breast cancer.

Proteomic analysis of pleomorphic dermal sarcoma reveals a fibroblastic cell of origin and distinct immune evasion mechanisms

Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers

Atypical fibroxanthoma and pleomorphic dermal sarcoma: Is superficial infiltration in subcutaneous tissue acceptable in AFX?

The large extracellular space of scalp: its relationship to brain scanning and cranial impedance plethysmography.

The Usefulness of Ultrasonography for Supporting the Differentiation, Diagnosis, and Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma

Treatment integrity in a home-based pre-reading intervention programme.

High intratumoural 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma

Genomic analysis of atypical fibroxanthoma

Pleomorphic Dermal Sarcoma: A Clinical and Histopathologic Emulator of Atypical Fibroxanthoma, but Different Biologic Behavior